Pfizer’s Indemnity Request Being Examined, Supply Likely In July: Centre

The government is examining Pfizer’s request for indemnity and will take a decision in the larger interest of people and on merit, NITI Aayog Member (Health) VK Paul said today.

Similar Articles

Comments

spot_img

Most Popular

You cannot copy content of this page

In Order to Strengthen Democracy, Citizens Should Bear the Cost of Impartial Journalism. Join 1-Rupee Campaign